Drug Discovery & Development | Cancer drug Treanda gets orphan status, but that won't save Teva's shrinking ... FiercePharma The orphan tag applies to use of Treanda for indolent B-cell non-Hodgkin lymphoma (iNHL) that has progressed during or within 6 months of treatment with rituximab or a regimen containing rituximab. Orphan status is granted to therapies intended to ... Teva Gets Additional Exclusivity for Treanda Teva Pharmaceutical Industries Limited : Teva Announces Additional Regulatory ... Teva gains additional regulatory exclusivity for Treanda |
